Synopsis: Vishal Mega Mart, Sai Life Sciences, Park Medi World, and Nephrocare Health Services are among the companies facing lock-in expiries worth over Rs. 20,000 crore today.
Lock-in expiries are closely watched by investors because they allow pre-IPO shareholders, promoters, anchor investors, and other early investors to sell their shares in the open market after a specified period. A large lock-in expiry can increase the number of shares available for trading, which may impact stock prices and market sentiment in the short term.
Today, several companies are set to witness lock-in expiries with a combined value exceeding Rs. 20,000 crore. Investors will be closely monitoring these stocks, as the release of locked-in shares could lead to higher trading activity and increased volatility. Here are some companies whose lock-in periods are ending today. Here are a few companies with a lock-in expiry worth more than Rs. 20,000 crore for today
Vishal Mega Mart Limited
With a market capitalization of Rs. 55,040.94 crores, the share of Vishal Mega Mart Limited has reached an intraday high of Rs. 119 per equity share, rising nearly 1.75 percent from its previous day’s close price of Rs. 116.95. Since then, the stock has retreated and is currently trading at Rs. 117.70 per equity share.
On June 17, 2026, Vishal Mega Mart Limited will witness the expiry of its lock-in period, making approximately 92.3 crore shares, representing 20 percent of the company’s total equity, eligible for trading. The value of these shares is estimated at around Rs. 10,863.71 crore.
Vishal Mega Mart Limited is an Indian retail supermarket and hypermarket chain offering a wide range of consumer goods, apparel, and groceries at value prices. It is one of India’s largest value-focused retail formats, serving both urban and semi-urban customers through hundreds of outlets across the country.
Sai Life Sciences Limited
With a market capitalization of Rs. 25,892.90 crores, the share of Sai Life Sciences Limited has reached an intraday high of Rs. 1,229.10 per equity share, rising nearly 1.83 percent from its previous day’s close price of Rs. 1,207. Since then, the stock has retreated and is currently trading at Rs. 1,220.35 per equity share.
On June 17, 2026, Sai Life Sciences Limited will witness the expiry of its lock-in period, making approximately 4.2 crore shares, representing 20 percent of the company’s total equity, eligible for trading. The value of the unlocked shares is estimated at nearly Rs. 5,125.47 crore.
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organization (CRDMO) headquartered in Hyderabad, Telangana. Founded in 1999, it partners with global pharmaceutical and biotechnology companies to accelerate drug discovery, development, and production, offering end-to-end small-molecule services.
Park Medi World Limited
With a market capitalization of Rs. 11,141.66 crore, the shares of Park Medi World Limited were currently trading at Rs. 257.95 per equity share, down nearly 4.52 percent from its previous day’s close price of Rs. 270.15 per share.
On June 17, 2026, Park Medi World Limited will witness the expiry of its lock-in period, making approximately 1.7 crore shares, representing 4 percent of the company’s total equity, eligible for trading. The value of the unlocked shares is estimated at nearly Rs. 438.52 crore.
Park Medi World Limited is an Indian healthcare company that operates a network of multi-super-specialty hospitals under the “Park Hospital” brand, primarily in North India. It focuses on affordable, high-volume medical and surgical care and has recently tapped public markets to fund expansion.
Nephrocare Health Services Limited
With a market capitalization of Rs. 7,333.40 crore, the shares of Nephrocare Health Services Limited were currently trading at Rs. 730.85 per equity share, down nearly 1.58 percent from its previous day’s close price of Rs. 742.60 per share.
On June 17, 2026, Nephrocare Health Services Limited will witness the expiry of its lock-in period, making approximately 5.1 crore shares, representing 51 percent of the company’s total equity, eligible for trading. The value of the unlocked shares is estimated at nearly Rs. 3,727.34 crore.
Nephrocare Health Services Limited is an Indian healthcare company focused on chronic kidney disease and dialysis services, operating under the brand name “NephroPlus.” It runs one of the largest dialysis networks in Asia, with centers across India and several international markets.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
